Toxin formation is such a common characteristic of bacteria as to make it seem plausible that other groups of micro6rganisms also produce toxins. Yet in the protozoa, for example, it has not been possible to demonstrate any producer of potent toxin-this despite energetic search in malaria and other diseases where various data have strongly suggested the action of a toxin. Failure to demonstrate toxin may occur because there is no toxin to demonstrate, and this seems to be the view generally assumed. The alternative is that the methods have not been suitable.t
It is the purpose of this paper to describe briefly and in a preliminary way a toxin which develops in vivo in animals infected with Toxoplasma. Whether this is to be interpreted as evidence for or against the protozoan nature of Toxoplasma will be discussed elsewhere. For convenience at present, the toxin will be referred to as "Toxotoxin" and considered a single substance, it being well understood that the toxin may later prove to have several components.
The toxoplasma strain utilized is the RH strain of human origin; it was originally isolated by A. B. Sabin about eight years ago' and was kindly furnished to the authors by H. A. Feldman. At present it is highly pathogenic for mice and rabbits, whereas lethal doses for these animals produce in rats the chronic type of latent infection with pseudocysts in the brain which has previously been described. ' Infection was maintained by serial mouse passage. The animals were injected intra-abdominally, and the peritoneal fluid which developed subsequently served for passage material. The customary inoculum was 0.1 cc. of a 10%o dilution in saline of the supernatant obtained after centrifuging for thirty minutes at 3600 r.p.m. So treated, mice usually survived about five days, showing a copious ascites at autopsy.
Peritoneal fluid is usually scanty until about forty-eight hours before death; then it increases quite rapidly and, if the mice are held until mori-*From the Department of Bacteriology, Yale University. This investigation was supported (in part) by a research grant from the Division of Research Grants and Fellowships of The National Institutes of Health, U. S. Public Health Service.
tSarcocystis produces a potent toxin, and an exception to the preceding statement may have to be made for this microorganism. Sarcocystis, however, is not universally held to be a protozoan. ' bund, 3 cc., or at times more, may be harvested from each mouse. The physical characteristics of the fluid vary considerably; some samples are viscid and coagulate spontaneously, either immediately or on standing; others are watery and show little coagulum on boiling.
The toxin is contained in the peritoneal fluid and can most readily be put in evidence by intravenous injection in mice. The manifestation is unmistakable; death invariably results when adequate doses, ranging from 0.1 to 0.5 cc., of whole peritoneal fluid supernate are so injected.
Spectacular rapidity of action is an outstanding characteristic of the toxin. When a lethal dose is injected intravenously, the animal is usually dead before it can be removed from the holding apparatus-sometimes before the needle is out of the vein. This occurs with minimum lethal doses established to the nearest 0.1 cc.; with a decrement of 0.1 cc. in the inoculum the animal usually shows no immediate ill effect. Occasional samples act more slowly and require ten to fifteen minutes to cause death. In general, if an animal survives for thirty minutes, it does not subsequently die from the acute effects of the toxin.
Symptoms are hard to follow in the most acute forms; the animal falls to one side, makes a few spasmodic movements of fore and hind quarters, and is dead. When the action is slower, the animal drops where deposited; if on the ventral surface, it will be prone and not raised upon its legs. It is inert, does not move, although it may respond to stimulation, and just before death falls to one side and has the kicking movements described. Respiratory distress is often a conspicuous symptom in animals which do not die. In such, breathing may be periodic with six to ten slow inspirations followed by a number of very hurried breaths, then the slow inspirations begin once more, and so on.
Peritoneal fluid harvested from different mice varies in toxicity. The usual lethal dose lies between 0.1 and 0.5 cc. for a mouse weighing 20 to 25 grams. In general, samples collected from moribund mice when the fluid is most copious contain less toxin in a unit volume. This direct relation between total volume and size of lethal dose suggests that the ascitic fluid collecting in the abdomen during the final forty-eight hours may have a diluting effect. A single mouse usually furnishes from four to ten lethal mouse doses by the method described.
The route of inoculation is of prime importance; the data thus far presented pertain to intravenous inoculations. Intraperitoneal injections of as many as five lethal intravenous doses are tolerated perfectly by mice. The range of susceptible normal animals is not yet ready for report. Toxoplasma-infected mice tested one to two days before death require approximately the same dose of toxin for lethal effect as do normal controls, indicating neither increased susceptibility nor resistance during the acute phase of the disease.
Toxotoxin is produced in vivo; no answer is available concerning its production in vitro since the organism has not been grown on cell-free medium. Whether it is an endotoxin, an exotoxin, or some type of reaction product between microorganism and host, cannot be answered as yet. There is no positive evidence suggesting an endotoxin. In numerous experiments the injection of toxoplasmata, washed in saline and then lysed by freezing and thawing, has not given toxic symptoms. While doses in excess of 6 X 107 intact organisms have not been given, it should be noted that the centrifuged supernatant from which these organisms were removed was highly toxic. Furthermore, supernatant toxic fluid stored with organisms has not changed detectably in titer. These data suggest that if an endotoxin is present at all in the washed toxoplasmata, it is not highly concentrated and is probably not the toxotoxin which is the subject of this report. It is known that washed toxoplasmata contain antigenic material which elicits a skin reaction in infected persons and animals.' Thus far toxotoxin resembles the toxin(s) formed within the body of animals infected with anthrax rather than the more usual bacterial toxins.
Toxotoxin is relatively stable. It is not decreased detectably by storage at room temperature or for twenty days at 50 C. It resists heating to 56°C. for thirty minutes and immersion in a boiling water bath for a half hour. Activity is diminished, however, by autoclaving at 15 lbs. pressure (1210 C.) for twenty minutes.
Toxicity is not appreciably reduced by eight minutes of exposure to bactericidal ultraviolet rays (2537 A, approximate delivered intensity 346 microwatts per cm2*). It has not been detectably altered by incubation with neutral formalin to a final concentration of 0.1% for four hours at 370 C., whereas after one month at 370 C. with formalin to 0.3%o final concentration, the titer was reduced to about one-half. Sodium sulfadiazine is effective in the treatment of toxoplasmosis5 but has shown no activity against the toxin. Mice first injected intra-abdominally with 10 mg. of drug, then, three hours later, with a minimum lethal dose of toxin previously incubated for thirty minutes at 370 C. with sodium sulfadiazine to 0.5%o final concentration, died promptly.
The toxin may be frozen and dried in the frozen state. It is then stable, * Calculated from manufacturer's data.
may be stored and, when reconstituted, is fully active. Such a method is one means of concentration of relatively dilute toxins; the rehydrated powders closely approximate the calculated lethal doses.
As yet not very much is known about the chemical constitution of toxotoxin. Activity is completely destroyed by the action of crystalline trypsin so that it is a protein, or at least contains a trypsin digestible protein fraction without which activity is nil. The toxin is stable at the pH of trypsin activity, so that loss of activity is not a pH effect. Dialyzed against saline in a collodion bag for ninety-four hours, the toxin did not diffuse out, for the lethal dose of bag contents increased only as the dilution factor. This indicates that toxicity is not associated with a substance of low molecular weight.
Studies on the antigenicity of the toxin have not yet been completed. It seems not impossible that toxotoxin plays some part in the lethal effects of the disease toxoplasmosis, bears upon the pathology of the disease, and is concerned in some of the immunological diagnostic tests in use. These subjects are now under investigation and will be the subject of subsequent reports. Conclusions 1. A toxin is produced in animals infected with Toxoplasmita. It has provisionally been named toxotoxin, cognizance being taken that it may prove to have more than one component.
2. The toxin develops in vivo and can be obtained several days before and up to death.
3. It is produced in the peritoneal fluid of infected animals and is lethal to mice by the intravenous route.
4. Notable characteristics of toxotoxin are its extreme rapidity of action and its heat stability.
5. All data thus far obtained suggest that it is not an endotoxin. 6. It is probably a protein or else contains a protein fraction without which activity is lost. Toxicity is not associated with a substance of low molecular weight.
